自性向是有效的辅助策略与氨酸激酶抑制剂结合使用吗?
Ahmed M Elshazly1,2, Jingwen Xu3, Nebras Melhem4
1Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, 401 College St., Richmond, VA 23298, USA.
Cancers
|September 14, 2024
概括
氨酸激酶抑制剂 (TKIs) 在癌症治疗中表现有前途,但面临抗药性. 自是一种细胞过程,可以帮助瘤在TKI中存活,也可以利用它来增强药物的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 氨酸激酶抑制剂 (TKI) 是有效的抗癌药物,向各种恶性瘤.
- 瘤细胞对TKI产生耐药性,限制了它们的长期疗效.
- 自是一种细胞应激反应,可以影响癌细胞的生存.
研究的目的:
- 在临床前癌症模型中审查自在对TKI的反应中的作用.
- 探索调节自能否可以克服TKI抵抗.
- 评估自抑制或调制作为TKI治疗的辅助策略.
主要方法:
- 关于自和TKI的临床前研究的文献综述.
- 对研究TKI反应和自的瘤模型的分析.
- 对检查自调节与TKI结合的研究的评估.
主要成果:
- 自通常具有保护作用,在TKI治疗下促进瘤细胞存活.
- 在某些情况下,自会表现出对癌细胞的细胞毒性作用.
- 自在TKI反应中的作用在不同的瘤模型中有所不同.
结论:
- 自在TKI反应中的双重作用需要仔细考虑治疗策略.
- 自调节为增强TKI疗效和克服耐药性的潜在途径.
- 需要进一步研究自抑制或调制作为TKI的辅助剂.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K